considering changes to ingredients and formats. The main thing that I took away from the conversa- tion today was that the expectations of our custom- er base are going to change and we need to be able to meet those expectations. How we meet them may still be a little bit up in the air, but it’s going to be a question of portions, it’s going to be a question of content, it’s going to be a question of availability that we provide our consumers. Final Reflection GLP-1 medications, originally used for diabetes and now widely adopted for weight loss, are rapidly changing consumer eating habits and reshap- ing the retail landscape. Users of these drugs are eating less, seeking high-protein, low-sugar, and prepared meal options while cutting back on impulse purchases like alcohol and large snacks. These shifts are prompting retailers to rethink product offerings, store layouts, and marketing strategies to align with evolving health-con- scious behaviors. As adoption grows, the ripple effects are expected to influence not only indi- viduals but entire households and broader food industry trends.
and telehealth visits driving adoption. However, as access tightens, cycling is expected to increase, particularly with seasonal motivations (e.g., weight loss for summer). She also pointed to adherence challenges with oral versions, despite their conve- nient appeal. Smartt also asked how major food and beverage manufacturers are adjusting. Frey suggested that manufacturer slowdowns aren’t solely due to GLP-1s. Broader macroeconomic trends such as tariff confusion and the “Make America Healthy” agenda are impacting manufacturers reaction time. That said, large manufacturers are begin- ning to collaborate on health-forward innovation,
Data Analysis and Manufacturing Changes Kevin Smartt , CEO, TXB Stores, shared that his company is tracking GLP-1 usage closely, citing a report that 12% of Americans were on a GLP-1 drug by the end of 2024. He asked about projec- tions, especially with consumers cycling on and off. Frey noted a 10-point increase in usage between September and February in her own survey data, with access through compounded pharmacies
The main thing that I took away from the conversation today was that the expectations of our customer base are going to change and we need to be able to meet those expectations. How we meet them may still be a little bit up in the air, but it’s going to be a question of portions, it’s going to be a question of content, it’s going to be a question of availability that we provide our consumers. Roy Strasburger , CEO, StrasGlobal, President, Compliance Safe, Vision Group Network Co-Founder
© 2025 Vision Group Network LLC
www.vgnsharing.com
Powered by FlippingBook